P14ARF sensitizes human osteosarcoma cells to cisplatin-induced apoptosis in a p53-independent manner

Xiang-Wei Yuan1, Xiao-Feng Zhu, Xiu-Fang Huang

  • 1Department of Orthopedic Surgery, The First Affiliated Hospital, Cancer Center, Sun Yat-sen University, Guangzhou, PR China.

Insights

The tumor suppressor p14ARF enhances apoptosis in osteosarcoma cells treated with cisplatin. This effect is independent of p53, suggesting p14ARF gene therapy combined with chemotherapy could treat osteosarcoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • The tumor suppressor p14ARF, encoded by the INK4a/ARF locus, plays a critical role in cell cycle arrest and apoptosis.
  • Disruption of p14ARF is common in human cancers, impacting therapeutic responses.

Purpose of the Study:

  • To investigate the role of p14ARF in mediating apoptosis induced by chemotherapeutic drugs.
  • To explore the potential of p14ARF as a therapeutic agent in osteosarcoma.

Main Methods:

  • Overexpression of p14ARF in human osteosarcoma cell lines (U2OS and MG63) via stable transfection.
  • Assessment of cell sensitivity to cisplatin-induced cytotoxicity and apoptosis.
  • Analysis of p53, Bax, and p21 expression levels.
  • Evaluation of p53's role using p53 siRNA.

Main Results:

  • Ectopic p14ARF expression sensitized both U2OS and MG63 cells to cisplatin-induced cytotoxicity and apoptosis.
  • In U2OS cells, sensitization correlated with increased p53, Bax, and p21.
  • This sensitization effect in U2OS cells was independent of p53 status, as confirmed by p53 siRNA experiments.

Conclusions:

  • p14ARF sensitizes human osteosarcoma cells to cisplatin-induced apoptosis through a p53-independent pathway.
  • Combining p14ARF gene transfer with conventional chemotherapy presents a promising strategy for osteosarcoma treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...